Wire Stories

Global Land Survey Equipment Market Forecast to 2028 – Development of Terrestrial Laser Scanners Presents Opportunities – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Land Survey Equipment Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Solution, Industry, Application…

2 years ago

POTTERY BARN ANNOUNCES GLOBAL COLLABORATION WITH DEEPIKA PADUKONE

Internationally Acclaimed Actor and Global Style Icon Will Collaborate with Pottery Barn as Part of Brand�s International Expansion SAN FRANCISCO--(BUSINESS…

2 years ago

VANCOUVER, British Columbia--(BUSINESS WIRE)--Qu�bec Nickel Corp. (CSE: QNI) (�Qu�bec Nickel Corp.� or the �Company�) is pleased to announce that it…

2 years ago

VANCOUVER, British Columbia--(BUSINESS WIRE)--Qu�bec Nickel Corp. (CSE: QNI) (�Qu�bec Nickel Corp.� or the �Company�) is pleased to announce that it…

2 years ago

ONE Championship Welcomes Stage Front VIP as Global VIP Experience Partner

Experiences for ONE�s U.S. Debut in 2023 to be Announced in Near Future SINGAPORE--(BUSINESS WIRE)--ONE Championship� (ONE), the world�s largest…

2 years ago

ONE Championship Welcomes Stage Front VIP as Global VIP Experience Partner

Experiences for ONE�s U.S. Debut in 2023 to be Announced in Near Future SINGAPORE--(BUSINESS WIRE)--ONE Championship� (ONE), the world�s largest…

2 years ago

Looking for a holiday gift? Choose Rokid Air and feel the thrill of carrying a big screen in your pocket

HANGZHOU, China--(BUSINESS WIRE)--The holiday season is back! How do you get your favorite entertainment whenever, wherever? During the holidays, augmented…

2 years ago

Datopotamab Deruxtecan Showed Promising Responses as Monotherapy and in Combination with Durvalumab in Patients with Metastatic Triple Negative Breast Cancer in Two Early Trials

Daiichi Sankyo and AstraZeneca�s TROP2 directed ADC showed an encouraging objective response rate of 32% and a manageable safety profile…

2 years ago

Datopotamab Deruxtecan Showed Promising Responses as Monotherapy and in Combination with Durvalumab in Patients with Metastatic Triple Negative Breast Cancer in Two Early Trials

Daiichi Sankyo and AstraZeneca�s TROP2 directed ADC showed an encouraging objective response rate of 32% and a manageable safety profile…

2 years ago

Takeda to Present Data at 64th American Society of Hematology (ASH) Annual Meeting, Demonstrating Commitment to Patients with Hematologic Cancers and Other Blood Diseases

? Company to Feature 15 Company-Sponsored and Nine Collaborative Abstracts in Oncology and Hematology ? Oral Presentations Include Updated Results…

2 years ago